Implementation of a Pediatric-to-adult Asthma Transition Program

NCT01521247 | Completed

• 1 other identifier: AJMG-2010
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

Despite the clear and often stated need, a formal transition program does not exist for asthma patients as they move from pediatric to adult care in Western Canada. This population is not having their health care needs met. The investigators proposed study would evaluate a well structured transition program designed to facilitate continuity of care for this at risk patient population. Primary hypothesis: A pediatric-to-adult asthma transition program will improve the asthma-specific quality of life of young asthma patients in the Calgary area over a 1 year period. Secondary hypothesis: A pediatric-to-adult asthma transition program will improve asthma control, decrease asthma exacerbations, and reduce health care utilization in young asthma patients in the Calgary area over a 1 year period.

Conditions

Asthma; Education

Keywords

Asthma; Transition program; Pediatric; Adult

Outcome Measures

Primary Outcomes (1)

• Asthma Quality of Life Questionnaire with Standardized Activities [AQLQ(S)]

  AQLQ(S) will be recorded at baseline, 6 months, and 12 months. The primary outcome will be the change in AQLQ(S) from baseline to 12 months.

  12 months

Secondary Outcomes (1)

• Asthma Control Questionnaire (ACQ)

  12 months

Study Arms (2)

Control group

NO INTERVENTION

Usual care.

Asthma Transition Program

OTHER

Asthma Transition Program

Other: Asthma Transition Program

Interventions

Asthma Transition Program OTHER

Asthma Education.

Also known as: Asthma Education and Referral.

Asthma Transition Program

Eligibility Criteria

• Age: 17 Years - 19 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• clinical diagnosis of asthma (as confirmed by a pediatric respirologist or pediatrician with asthma expertise, and including evidence of variable airflow obstruction, bronchial hyperresponsiveness, airway inflammation, and/or response to therapy)

You may not qualify if:

• patients who are known to be non-adherent within the Calgary Regional Pediatric Asthma Clinic (defined as \>50% missed appointments over a 2 year period)
• patients unable to complete pulmonary function testing
• patients with a history of significant respiratory comorbid conditions (including history of cystic fibrosis, alpha-1 antitrypsin deficiency, and lung transplant - rhinosinusitis patients will not be excluded)
• patients unable to provide consent.

Sponsors & Collaborators

• University of Calgary: lead

Study Sites (1)

Calgary Regional Pediatric Asthma Clinic

Calgary, Alberta, T3B 6A8, Canada

Location

MeSH Terms

Conditions

Asthma

Interventions

Referral and Consultation

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Intervention Hierarchy (Ancestors)

Professional Practice; Organization and Administration; Health Services Administration

Study Officials

• Mary Noseworthy, MD

  Alberta Children's Hospital

  STUDY DIRECTOR

• Rodel Padua, RRT

  STUDY DIRECTOR

• Sheldon Spier, MD

  Alberta Children's Hospital

  STUDY DIRECTOR

• Ward Flemons, MD

  University of Calgary

  STUDY DIRECTOR

• Warren Davidson, MD

  University of Calgary

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: January 23, 2012
• First Posted: January 30, 2012
• Study Start: April 1, 2010
• Primary Completion: July 1, 2014
• Study Completion: July 1, 2015
• Last Updated: September 9, 2016

Record last verified: 2016-09

Locations

CA (1)